Pola Pengobatan Dan Analisis Potensi Interaksi Obat Pada Pasien Anak Demam Berdarah Dengue (Dbd) Di Rumah Sakit Kalimantan Timur

Helda Rahma, Muthia Dewi Marthilia Alim
{"title":"Pola Pengobatan Dan Analisis Potensi Interaksi Obat Pada Pasien Anak Demam Berdarah Dengue (Dbd) Di Rumah Sakit Kalimantan Timur","authors":"Helda Rahma, Muthia Dewi Marthilia Alim","doi":"10.47859/bhpj.v5i1.322","DOIUrl":null,"url":null,"abstract":"Background: Dengue hemorrhagic fever is caused by transmission of the dengue virus by the Aedes aegypti mosquito. Dengue hemorrhagic fever is common in tropical countries such as Indonesia, where new cases are found every year. According to WHO that dengue fever is the leading cause of hospitalization for children. Dengue hemorrhagic disease is more susceptible to infection in children because the child's immune system is still very weak, so the virus is easy to multiply quickly in the body. Knowing the pattern of treatment and analysis of potential drug interactions in pediatric patients with dengue hemorrhagic fever at the East Kalimantan Hospital.\nMethods: The research is non-experimental observational with a descriptive research design. The approach method used is the cross sectional method. Identification of data collection is carried out retrospectively, by taking sources from medical records for the years 2020-2021.\nResults: Of  the 47 patient samples, the most cases were male patients as many as 27 patients (57%) with the age of 11 years as many as 11 patients (23%) with a length of stay of less than 7 days as many as 45 patients (96%). Based on the pattern of treatment, the most widely used therapy was the rehydration group (RL) 28 patients (60%). In the case of drug interactions occurred as many as 2 cases (3%).\nConclusion: In this study show that there are cases of drug interactions.","PeriodicalId":403812,"journal":{"name":"Bali Health Published Journal","volume":"14 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bali Health Published Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.47859/bhpj.v5i1.322","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Dengue hemorrhagic fever is caused by transmission of the dengue virus by the Aedes aegypti mosquito. Dengue hemorrhagic fever is common in tropical countries such as Indonesia, where new cases are found every year. According to WHO that dengue fever is the leading cause of hospitalization for children. Dengue hemorrhagic disease is more susceptible to infection in children because the child's immune system is still very weak, so the virus is easy to multiply quickly in the body. Knowing the pattern of treatment and analysis of potential drug interactions in pediatric patients with dengue hemorrhagic fever at the East Kalimantan Hospital. Methods: The research is non-experimental observational with a descriptive research design. The approach method used is the cross sectional method. Identification of data collection is carried out retrospectively, by taking sources from medical records for the years 2020-2021. Results: Of  the 47 patient samples, the most cases were male patients as many as 27 patients (57%) with the age of 11 years as many as 11 patients (23%) with a length of stay of less than 7 days as many as 45 patients (96%). Based on the pattern of treatment, the most widely used therapy was the rehydration group (RL) 28 patients (60%). In the case of drug interactions occurred as many as 2 cases (3%). Conclusion: In this study show that there are cases of drug interactions.
东加里曼丹医院登革热患儿患者的治疗模式和潜在药物相互作用的分析
背景:登革出血热是由埃及伊蚊传播登革热病毒引起的。登革出血热在印度尼西亚等热带国家很常见,每年都会发现新病例。据世卫组织称,登革热是儿童住院的主要原因。登革出血性疾病在儿童中更容易感染,因为儿童的免疫系统还很弱,所以病毒很容易在体内快速繁殖。了解东加里曼丹医院登革热出血热患儿的治疗模式和潜在药物相互作用分析。方法:本研究为非实验观察性研究,采用描述性研究设计。采用的方法是横截面法。通过从2020-2021年的医疗记录中提取来源,回顾性地确定数据收集情况。结果:47例患者样本中,男性患者最多,最多27例(57%),年龄11岁最多11例(23%),住院时间小于7天最多45例(96%)。根据治疗模式,最广泛使用的治疗方法是补液组(RL) 28例(60%)。在发生药物相互作用的情况下多达2例(3%)。结论:本研究显示存在药物相互作用的病例。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信